Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
  1. Quite A Comeback For This Momentum ETF

    Headlines

    Thu, 21 Aug 2014

    beloved exchange traded funds such as the Global X Social Media Index ETF (NASDAQ: SOCL ) and the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ) to ominous flirtations with bear markets . Imagine how bad things were during the March/April

  2. Like I said, we're almost free of Ebola

    Headlines

    Wed, 20 Aug 2014

    Chukwu said that Nigeria had only two known cases of Ebola and the county would be free of the disease within a week. The outbreak has sickened 2,240 people to date with 1,229 fatalities. ETFs: IBB , BIB , IRY , IXJ , BIS Post your comment!

  3. New Issue- IBB prices 100 mln euro 2022 FRN

    Headlines

    Thu, 14 Aug 2014

    Notes Launched under issuer's Debt Issuance Programme

  4. New Issue- IBB prices 50 mln euro 2019 FRN

    Headlines

    Thu, 14 Aug 2014

    Notes Launched under issuer's Debt Issuance Programme

  5. New Issue- IBB prices 75 mln euro 2020 FRN

    Headlines

    Thu, 7 Aug 2014

    Notes Launched under issuer's Debt Issuance Programme

  6. Fitch Rates Investitionsbank Berlin IDR 'AAA'; Outlook Stable

    Headlines

    Mon, 28 Jul 2014

    was released by the rating agency) FRANKFURT/LONDON, July 28 (Fitch) Fitch Ratings has assigned Investitionsbank Berlin ( IBB ) a Long-term Issuer Default Rating (IDR) of 'AAA', Short-term IDR of 'F1+', Support Rating of '1' and Support

  7. Conatus Pharmaceuticals: Large Upside With Attractive Risk And Income Profiles

    Headlines

    Mon, 28 Jul 2014

    By Left Banker : Since my recent retirement, I have been focusing research efforts on refining my retirement income account. Thus in my recent writings on Seeking Alpha I have emphasized retirement income strategies. In addition to that income account, I also maintain a growth portfolio. Here, I ...

  8. The Fed Calls Out Biotech... Is It Time To Sell?

    Headlines

    Thu, 24 Jul 2014

    When the world’s top central banker speaks, markets pay very close attention. Last week, Federal Reserve Chair Janet Yellen was on Capitol Hill delivering her semi-annual testimony on monetary policy. And in her remarks she stuck mostly to the script signaling that a high degree of monetary policy

  9. Today's Market: Biotech Names Rallying Today

    Headlines

    Wed, 23 Jul 2014

    larger players in the sector by buying ETFs, such as the SPDR S&P Biotech ETF (NY XBI ) and the iShares Nasdaq Biotechnology (NASDAQ: IBB ) with our preference being the SPDR S&P Biotech due to it having less exposure to the more speculative

  10. Physician payment data to be made public on September 30

    Headlines

    Tue, 15 Jul 2014

    for covered recipients. Predictably, medical industry observers are confident that the disclosures will generate substantial interest from a wide swath of the health care sector. ETFs: IBB , BIB , IRY , IXJ , BIS , DRGS Post your comment!

« Prev1234Next »
Content Partners